To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Management and outcomes of foramen magnum stenosis in children with achondroplasia at a single center over 15 years
Department of Neurosurgery, Division of Pediatric Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Pediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden; University Hospital, Örebro, Sweden.
Department of Women’s and Children’s Health, Division of Pediatric Endocrinology, Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Department of Women’s and Children’s Health, Division of Pediatric Endocrinology, Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Show others and affiliations
2024 (English)In: Journal of Neurosurgery: Pediatrics, ISSN 1933-0707, E-ISSN 1933-0715, Vol. 34, no 5, p. 470-478Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: Achondroplasia is associated with foramen magnum stenosis (FMS), which can lead to sudden unexpected death in infants. There is no wide consensus regarding the best management of FMS. This study aimed to analyze the prevalence of FMS in a cohort of children with achondroplasia and to evaluate screening and neurosurgical interventions of FMS regarding its effects and complications.

METHODS: The authors conducted a retrospective cohort study including all children with achondroplasia assessed or treated at Karolinska University Hospital between September 2005 and June 2020. The severity of FMS was graded using the MRI Achondroplasia Foramen Magnum Score (AFMS). The AFMS was correlated with neurological examinations and polysomnography (PSG) results.

RESULTS: Severe FMS (AFMS 3-4) was present in 35% of the 51 children included in the study. As many as 65% of the children in the cohort underwent foramen magnum decompression (FMD). Neurological examination had a high specificity (94%) but a low sensitivity (28%) for severe FMS. Signs of central apnea on PSG did not correlate with severity of FMS (p = 0.735). Surgery improved FMS (p < 0.001) with a nonsignificant trend of decreased central apnea (p = 0.070), but carried a 9% risk of severe surgery- and anesthesia-related complications.

CONCLUSIONS: This study confirmed previous reports that severe FMS is common in children with achondroplasia, that neurological symptoms may be absent even in severe FMS, and that FMD improves FMS and may improve central apnea. The finding that neurological examination had a low sensitivity for severe FMS supports the recommendation that all children with achondroplasia should undergo early MRI.

Place, publisher, year, edition, pages
American Association of Neurological Surgeons , 2024. Vol. 34, no 5, p. 470-478
Keywords [en]
achondroplasia, foramen magnum stenosis, foramen magnum decompression, surgical complications, magnetic resonance imaging, congenital
National Category
Pediatrics
Identifiers
URN: urn:nbn:se:oru:diva-118527DOI: 10.3171/2024.6.PEDS23586ISI: 001381996100006PubMedID: 39213664Scopus ID: 2-s2.0-85208449171OAI: oai:DiVA.org:oru-118527DiVA, id: diva2:1927718
Funder
Swedish Research Council, 2021-01807IngaBritt and Arne Lundberg’s Research FoundationRegion Stockholm, RS2020-0731Novo Nordisk Foundation, NNF16OC0021508Edith och Erik Fernströms Stiftelse för medicinsk forskningSällskapet BarnavårdStiftelsen Frimurare Barnhuset i StockholmNyckelfondenÖrebro UniversityKarolinska Institute
Note

This work was supported by grants from the Swedish Research Council (no. 2021-01807), IngaBritt och Arne Lundbergs forskningsstiftelse, the Stockholm County Council (no. RS2020-0731), Novo Nordisk Foundation (no. NNF16OC0021508), Erik and Edith Fernström Foundation for Medical Research, Promobilia, Sällsynta Fonden, Sällskapet Barnavård, Stiftelsen Frimurare Barnhuset i Stockholm, Nyckelfonden, Örebro University (Örebro, Sweden), and Karolinska Institutet (Stockholm, Sweden).

Available from: 2025-01-15 Created: 2025-01-15 Last updated: 2025-01-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Nilsson, Ola

Search in DiVA

By author/editor
Nilsson, Ola
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Journal of Neurosurgery: Pediatrics
Pediatrics

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 29 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf